Obesity doctor Spencer Nadolsky explains the different GLP-1 medicines
A short reposted clip where Dr Nadolsky walks through how the various GLP-1 drugs differ from one another.
Recap by typeshit. Post by @FrankfurtPK on X.
A short reposted clip where Dr Nadolsky walks through how the various GLP-1 drugs differ from one another.
Recap by typeshit. Post by @FrankfurtPK on X.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
A clinician reminds patients on GLP-1 medications that their bodies are not flawed or broken. A short brand post with a body-positive message.
Polskie Radio looks at a newer weight loss drug being framed as a successor to Ozempic. The material is thin, so tap through for which drug it is.
Loading…